# E. Coli Nissle 1917 - Suspension for Infection Prophylaxis

> **NCT02802059** · PHASE3 · COMPLETED · sponsor: **Ardeypharm GmbH** · enrollment: 567 (actual)

## Conditions studied

- Infections

## Interventions

- **DRUG:** EcN-Suspension
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02802059
- **Lead sponsor:** Ardeypharm GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-07
- **Primary completion:** 2020-10-12
- **Final completion:** 2020-10-12
- **Target enrollment:** 567 (ACTUAL)
- **Last updated:** 2020-10-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02802059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02802059, "E. Coli Nissle 1917 - Suspension for Infection Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02802059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*